Free Trial
→ SpaceX is offering you shares. Don't take them. (From Behind the Markets) (Ad)tc pixel Free OABIW Stock Alerts

OmniAb (OABIW) Competitors

$0.10 +0.00 (+0.10%)
As of 06/5/2026 03:58 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

OABIW vs. SXTPW, DRTSW, APLMW, BIVIW, and CDIOW

Should you buy OmniAb stock or one of its competitors? MarketBeat compares OmniAb with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with OmniAb include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). These companies are all part of the "biotechnology" industry.

How does OmniAb compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and OmniAb (NASDAQ:OABIW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, valuation, media sentiment, analyst recommendations and risk.

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
OmniAb N/A N/A N/A

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than OmniAb. MarketBeat recorded 1 mentions for 60 Degrees Pharmaceuticals and 0 mentions for OmniAb. 60 Degrees Pharmaceuticals' average media sentiment score of 0.00 equaled OmniAb'saverage media sentiment score.

Company Overall Sentiment
60 Degrees Pharmaceuticals Neutral
OmniAb Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A
OmniAb$28.94MN/AN/AN/AN/A

Summary

60 Degrees Pharmaceuticals and OmniAb tied by winning 1 of the 2 factors compared between the two stocks.

How does OmniAb compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and OmniAb (NASDAQ:OABIW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, valuation, media sentiment, analyst recommendations and risk.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
OmniAb N/A N/A N/A

In the previous week, Alpha Tau Medical's average media sentiment score of 0.00 equaled OmniAb'saverage media sentiment score.

Company Overall Sentiment
Alpha Tau Medical Neutral
OmniAb Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
OmniAb$28.94MN/AN/AN/AN/A

Summary

OmniAb beats Alpha Tau Medical on 1 of the 1 factors compared between the two stocks.

How does OmniAb compare to Apollomics?

Apollomics (NASDAQ:APLMW) and OmniAb (NASDAQ:OABIW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, media sentiment, dividends, analyst recommendations and profitability.

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
OmniAb N/A N/A N/A

In the previous week, Apollomics' average media sentiment score of 0.00 equaled OmniAb'saverage media sentiment score.

Company Overall Sentiment
Apollomics Neutral
OmniAb Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
OmniAb$28.94MN/AN/AN/AN/A

Summary

OmniAb beats Apollomics on 1 of the 1 factors compared between the two stocks.

How does OmniAb compare to BioVie?

OmniAb (NASDAQ:OABIW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, valuation, profitability, risk, dividends, earnings and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
OmniAbN/A N/A N/A
BioVie N/A N/A N/A

In the previous week, OmniAb's average media sentiment score of 0.00 equaled BioVie'saverage media sentiment score.

Company Overall Sentiment
OmniAb Neutral
BioVie Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OmniAb$28.94MN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Summary

OmniAb beats BioVie on 1 of the 1 factors compared between the two stocks.

How does OmniAb compare to Cardio Diagnostics?

OmniAb (NASDAQ:OABIW) and Cardio Diagnostics (NASDAQ:CDIOW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings, analyst recommendations and media sentiment.

Company Net Margins Return on Equity Return on Assets
OmniAbN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

In the previous week, OmniAb's average media sentiment score of 0.00 equaled Cardio Diagnostics'average media sentiment score.

Company Overall Sentiment
OmniAb Neutral
Cardio Diagnostics Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OmniAb$28.94MN/AN/AN/AN/A
Cardio Diagnostics$16.57KN/AN/AN/AN/A

Summary

OmniAb beats Cardio Diagnostics on 1 of the 1 factors compared between the two stocks.

Get OmniAb News Delivered to You Automatically

Sign up to receive the latest news and ratings for OABIW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OABIW vs. The Competition

Export
MetricOmniAbBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$460.38M$6.68B$11.99B
Dividend YieldN/A3.87%2.67%5.55%
P/E RatioN/A3.1524.0323.62
Price / SalesN/A6,606.57519.33112.45
Price / CashN/A13.1342.2354.60
Price / BookN/A83.479.736.35
Net IncomeN/A-$96.07M$3.57B$337.59M
7 Day PerformanceN/A-1.89%-1.26%-2.51%
1 Month PerformanceN/A1.04%0.82%-0.69%
1 Year PerformanceN/A64.50%24.09%25.37%

OmniAb Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OABIW
OmniAb
N/A$0.10
flat		N/A-56.6%$0.00$28.94MN/A106
SXTPW
60 Degrees Pharmaceuticals
N/A$0.04
-1.8%		N/A-23.1%$0.00$1.00MN/A2
DRTSW
Alpha Tau Medical
N/A$2.54
+32.0%		N/A+805.0%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.01
+27.6%		N/A-37.6%$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.32
-3.9%		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:OABIW) was last updated on 6/6/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
BUY THIS: Claim a backdoor stake in SpaceX before June 12
Marc Chaikin, the Wall Street veteran who spotted Nvidia before a 45,000% run, says there's a simple trade ava...
Chaikin Analytics | Sponsoredtc pixel
One hidden supplier shipped 5 billion parts to SpaceX
Most investors are focused on the historic $1.75 trillion SpaceX IPO expected around June 30. But there's a le...
Weiss Ratings | Sponsoredtc pixel
I paid $5,000 to hear Elon say this
One investor paid $5,000 to be in a private room with Elon Musk in Los Angeles - and what he heard confirmed a...
InvestorPlace | Sponsoredtc pixel
How to get into the SpaceX IPO before June 12
Former tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...
Brownstone Research | Sponsoredtc pixel
Goldman Sachs just told you what to buy (most people missed it)
Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...
Behind the Markets | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel